Year: 2026
Type: preprint
Study design: Observational Study
Abstract: Background and Aim: Recurrent ischemic stroke is a major contributor to long-term disability and healthcare burden. Identifying clinical and modifiable factors associated with recurrence is essential for improving secondary prevention. This study aimed to investigate factors associated with recurrent ischemic stroke, with particular emphasis on vascular risk factors, stroke severity, rehabilitation, lifestyle modification, and adherence to preventive pharmacotherapy. Methods In this retrospective case-control study, 194 patients admitted with ischemic stroke to Imam Reza Training Hospital, Tabriz, Iran, between 2016 and 2023 were evaluated. The study included 97 patients with recurrent ischemic stroke. Demographic characteristics, vascular risk factors, National Institutes of Health Stroke Scale (NIHSS), modified Rankin Scale (mRS), rehabilitation utilization, lifestyle factors, and use of secondary prevention medications were assessed. Between-group and within-patient comparisons were performed using appropriate parametric and non-parametric statistical tests. Results A history of hypertension was more common among patients with recurrent stroke than controls (83.5% vs. 60.8%, p < 0.001). Patients who subsequently experienced recurrent stroke had lower NIHSS scores at initial admission (median 8 vs. 10, p = 0.057) and at discharge (median 5 vs. 9, p = 0.003) than controls. Among patients with recurrent stroke, stroke severity increased at the time of recurrence, with median NIHSS increasing from 8 to 10 (p = 0.019). During the interval between the first and recurrent stroke, use of anticoagulants decreased from 28.6% to 17.5% (p < 0.001), lipid-lowering therapy from 70.1% to 49.5% (p = 0.001), and antiplatelet therapy from 72.2% to 48.4% (p < 0.001). At recurrence, fasting blood glucose increased from 109 to 117 mg/dL (p < 0.001), while HDL cholesterol decreased from 36 to 33 mg/dL (p = 0.002). Conclusion Recurrent ischemic stroke was associated with hypertension, a history of previous cerebrovascular events, reduced use of secondary prevention medications, lower utilization of inpatient rehabilitation, and adverse metabolic changes. Although patients who subsequently experienced recurrence initially had less severe strokes than controls, neurological severity increased at the recurrent event. These findings highlight the importance of sustained pharmacological treatment, vascular risk-factor control, and rehabilitation as components of secondary stroke prevention. Prospective multicenter studies are warranted to determine the extent to which improving adherence and risk-factor management can reduce recurrence.
Source: Research Square
Institution: Tabriz University of Medical Sciences
Language: English
Subfield: Clinical Neurology
Field: Medicine
Domain: Health Sciences
Keywords: ischemic stroke recurrence, secondary stroke prevention, hypertension, stroke severity, anticoagulation, antiplatelet therapy, lipid-lowering therapy, stroke rehabilitation, lifestyle modification, fasting blood glucose, HDL cholesterol, vascular risk factors, NIHSS, modified Rankin Scale, cerebrovascular events, Iranian patients
Open Access status: green
OpenAlex ID: W7236716174
